Comparative Pharmacology
Head-to-head clinical analysis: CONCENTRAID versus STIMATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CONCENTRAID versus STIMATE.
CONCENTRAID vs STIMATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
CONCENTRAID is a centrally acting alpha-2 adrenergic agonist that reduces sympathetic outflow from the brainstem, leading to decreased peripheral vascular resistance and reduced heart rate.
Desmopressin acetate is a synthetic analog of the natural pituitary hormone 8-arginine vasopressin (ADH). It acts as a V2 receptor agonist in the renal collecting ducts, increasing water permeability and promoting water reabsorption, thereby reducing urine output. It also increases plasma levels of von Willebrand factor and factor VIII via V2 receptor stimulation on endothelial cells.
100 mg orally once daily, administered with or without food.
Intranasal: 1 spray (1.5 mg) into one nostril, 1 hour prior to voiding or on awakening for bedwetting; maximum 2 sprays per day.
None Documented
None Documented
Clinical Note
moderateNorgestimate + Atazanavir
"The serum concentration of Atazanavir can be increased when it is combined with Norgestimate."
Clinical Note
moderateNorgestimate + Fosamprenavir
"The serum concentration of the active metabolites of Fosamprenavir can be reduced when Fosamprenavir is used in combination with Norgestimate resulting in a loss in efficacy."
Clinical Note
moderateNorgestimate + Cobicistat
"The serum concentration of Cobicistat can be increased when it is combined with Norgestimate."
Clinical Note
moderateTerminal elimination half-life is 4-6 hours in adults with normal renal function; prolonged to 8-12 hours in moderate renal impairment (CrCl 30-50 mL/min) and up to 20 hours in severe renal impairment (CrCl <30 mL/min), necessitating dose adjustment.
Terminal elimination half-life is approximately 3-4 hours in healthy adults, but may be prolonged in patients with renal impairment or in older adults.
Renal excretion of unchanged drug accounts for 60-70% of the administered dose; fecal elimination via biliary excretion contributes 20-25%; the remaining 5-10% is metabolized and excreted renally as inactive metabolites.
Desmopressin is primarily excreted renally, with approximately 60-70% of the dose recovered unchanged in urine within 24 hours. The remaining fraction is metabolized hepatically and eliminated via feces.
Category C
Category C
Antidiuretic Hormone Analog
Antidiuretic Hormone Analog
Norgestimate + Boceprevir
"The serum concentration of Boceprevir can be increased when it is combined with Norgestimate."